Atara biotherapeutics to participate in cell therapy panel discussion at the cowen 44th annual health care conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will participate in a cell therapy panel discussion at the cowen 44th annual health care conference on wednesday, march 6, 2024 at 6:10 a.m. pst /.
ATRA Ratings Summary
ATRA Quant Ranking